Financials C21 Investments Inc.

Equities

CXXI

CA12675Q1019

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:59:59 2024-04-26 pm EDT 5-day change 1st Jan Change
0.415 CAD +5.06% Intraday chart for C21 Investments Inc. +1.22% +29.69%

Valuation

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Capitalization 1 6.645 35.01 41.78 141.8 54.74 30.67
Enterprise Value (EV) 2 6.388 75.86 74.78 162.9 71.21 40.91
P/E ratio -7.19 x -1.02 x -1.1 x -21.5 x 4.98 x 223 x
Yield - - - - - -
Capitalization / Revenue - 13,541,656 x 1,108,196 x 3,924,889 x 1,659,621 x 1,061,535 x
EV / Revenue - 29,339,830 x 1,983,212 x 4,507,810 x 2,159,079 x 1,416,161 x
EV / EBITDA - -6,651,972 x 33,633,726 x 16,934,190 x 6,562,329 x 7,215,664 x
EV / FCF -16 x -12 x 18.5 x 46.2 x 30.3 x 5.45 x
FCF Yield -6.24% -8.32% 5.4% 2.16% 3.3% 18.3%
Price to Book 77 x 2.16 x 3.08 x 5.78 x 1.56 x 0.89 x
Nbr of stocks (in thousands) 5,980 45,064 89,276 113,299 120,048 120,048
Reference price 3 1.111 0.7769 0.4680 1.252 0.4560 0.2554
Announcement Date 3/21/18 5/31/19 7/14/20 5/31/21 8/15/22 6/13/23
1USD in Million2CAD in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Net sales - 2.586 37.71 36.13 32.98 28.89
EBITDA - -11.4 2.223 9.617 10.85 5.67
EBIT 1 -0.7057 -12.03 -1.181 7.522 9.755 4.298
Operating Margin - -465.16% -3.13% 20.82% 29.58% 14.88%
Earnings before Tax (EBT) 1 -0.7736 -23.6 -28.84 -3.74 17.13 4.191
Net income 1 -0.7736 -23.6 -32.56 -6.106 10.92 0.2932
Net margin - -912.82% -86.34% -16.9% 33.1% 1.01%
EPS 2 -0.1546 -0.7613 -0.4245 -0.0582 0.0915 0.001143
Free Cash Flow 1 -0.3989 -6.31 4.039 3.522 2.347 7.501
FCF margin - -244.03% 10.71% 9.75% 7.12% 25.97%
FCF Conversion (EBITDA) - - 181.67% 36.62% 21.63% 132.31%
FCF Conversion (Net income) - - - - 21.5% 2,558.36%
Dividend per Share - - - - - -
Announcement Date 3/21/18 5/31/19 7/14/20 5/31/21 8/15/22 6/13/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: January 2018 2019 2020 2021 2022 2023
Net Debt 1 - 40.8 33 21.1 16.5 10.2
Net Cash position 1 0.26 - - - - -
Leverage (Debt/EBITDA) - -3.582 x 14.84 x 2.19 x 1.518 x 1.807 x
Free Cash Flow 1 -0.4 -6.31 4.04 3.52 2.35 7.5
ROE (net income / shareholders' equity) 410% -223% -188% -31.4% 45.2% 4.06%
ROA (Net income/ Total Assets) -216% -19.3% -1.06% 7.22% 9.48% 4.47%
Assets 1 0.3582 122 3,063 -84.59 115.2 6.557
Book Value Per Share 2 0.0100 0.3600 0.1500 0.2200 0.2900 0.2900
Cash Flow per Share 2 0.0400 0.1500 0.0300 0.0500 0.0300 0.0200
Capex - 0.21 0.51 0.23 2.56 0.44
Capex / Sales - 8.24% 1.35% 0.63% 7.77% 1.53%
Announcement Date 3/21/18 5/31/19 7/14/20 5/31/21 8/15/22 6/13/23
1CAD in Million2CAD
Estimates
  1. Stock Market
  2. Equities
  3. CXXI Stock
  4. Financials C21 Investments Inc.